Behind the white picket fence of a weatherboard home in Hawthorn in Melbourne’s inner east, Luke Campbell was asleep on his ...

Cambridge Vision Technology utilises AI-based technology to detect Alzheimer’s disease early on by using ocular biomarkers ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Researchers confirm plasma pTau181 is a strong predictor for Alzheimer's in patients with mild cognitive impairment, offering ...

A new study helps explain why having ApoE4—the gene variant most closely linked to Alzheimer's disease—increases the risk of ...

In the other study, the team used tau protein itself as bait, because the misfolded tau seen in Alzheimer’s stick together ...

The ALPS index effectively distinguishes individuals with SCD from those with normal cognition and is correlated with amyloid beta burden.

A hallmark of Alzheimer's is the accumulation of beta-amyloid protein in the brain, which is linked to cell death and tissue ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

The FDA’s approval of Kisunla demonstrates a positive change in Alzheimer disease management. Offering illness pathology therapy and the option of treatment conclusion after reaching therapeutic goals ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

The scientists looked at two brain scans and found that areas with more amyloid-beta showed increased brain activity, with ...